Atlas Trials

A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)

Clinical trial NCT02837783 · TERMINATED

Trial details

NCT number
NCT02837783
Sponsor
Ironwood Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Irritable Bowel Syndrome Characterized by Constipation
Start date
2016-12-21
Primary completion
2018-10-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.